E-Learning Opportunity To Specifically Focus On Trials Of Biologics

Main Category: Clinical Trials / Drug Trials
Also Included In: Conferences;  Biology / Biochemistry;  Pharmacy / Pharmacist
Article Date: 22 Oct 2009 - 3:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

WHO:
The American Association of Pharmaceutical Scientists (AAPS) is a professional, scientific society of approximately 12,000 members employed in industry, academia, government and other research institutes worldwide. Founded in 1986, AAPS provides a dynamic international forum for the exchange of knowledge among scientists to enhance their contributions to public health. AAPS offers timely scientific programs, on-going education, information resources, opportunities for networking, and professional development.

WHAT:
AAPS is pleased to present the complimentary eLearning Webinar on Use of PKPD Modeling for Starting Dose Selection in First-in-Human Trials of Biologics. This module is organized by the AAPS Clinical Pharmacology and Translational Research Section. This Webinar will be conducted by Balaji Agoram, Ph.D.

WHY:
The purpose of this free Webinar is to illustrate the use of pharmacokinetic/pharmacodynamic models to select rational starting doses in clinical trials within the Minimum Anticipated Biological Effect Level (MABEL) principle using literature data and through simulations. Participants will gain understanding of the complex biologic drug-receptor interaction dynamics and the multiple factors affecting the dose-receptor occupancy relationship.

WHEN:
October 29, 2009
12:30 PM to 2:00 PM EDT

For additional information about the workshop, and to register, visit http://www.aapspharmaceutica.com/webinars/PKPD.

Source:
Joseph Catapano
American Association of Pharmaceutical Scientists